Dupont Capital Management Corp Atara Biotherapeutics, Inc. Transaction History

Dupont Capital Management Corp

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Jul 30, 2021	SELL	$12.89 - $16.58 $160,196 - $206,056	-12,428 Closed	0 $0
Q1 2021 Apr 29, 2021	BUY	$14.0 - $20.72 $173,992 - $257,508	12,428 New	12,428 $178,000
Q1 2019 Apr 30, 2019	SELL	$28.4 - $41.74 $292,946 - $430,548	-10,315 Closed	0 $0
Q1 2018 May 02, 2018	BUY	$18.0 - $48.35 $185,670 - $498,730	10,315 New	10,315 $402,000

85M

18.4K

51.3K

Ticker ATRA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 94,362,304
Market Cap $710M
Description
Atara Biotherapeutics, Inc., an off-the-shelf T-cell immunotherapy company, develops treatments for patients with cancer, autoimmune, and viral diseases in the United States. It is developing tabelecleucel, a T-cell immunotherapy that is Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferat...

Get notified when there are updates to the investment portfolio of Dupont Capital Management Corp, based on Form 13F filings with the SEC.

Stay updated on Dupont Capital Management Corp with notifications on news.